Filing Details

Accession Number:
0001415889-24-026974
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-15 17:34:54
Reporting Period:
2024-11-14
Accepted Time:
2024-11-15 17:34:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1974200 Jolanda Howe C/O Mirum Pharmaceuticals, Inc.
989 E Hillsdale Blvd., Suite 300
Foster City CA 94404
Svp, Global Controller No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-14 2,500 $2.94 4,926 No 4 M Direct
Common Stock Disposition 2024-11-14 2,500 $47.10 2,426 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-11-14 2,500 $0.00 2,500 $2.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,900 2029-03-11 No 4 M Direct
Footnotes
  1. 1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter.